This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christopher S. Oh and His CAR-T Patent
Introduction
Christopher S. Oh is an inventor associated with the University of California and based in Oakland, California. His patent work includes an invention focused on chimeric antigen receptor modified T-cells, commonly known as CAR-T cells, for cancer treatment.
Latest Patents
Oh is listed as an inventor on 1 patent: “Chimeric Antigen Receptor Modified T-Cells (CAR-T) for the Treatment of Hematological and Solid Tumor Cancers.” The invention concerns CAR-T approaches directed at both hematological cancers and solid tumors.
Career Highlights
Oh’s listed patent reflects work in cellular immunotherapy and the development of engineered T-cell treatments. The patent identifies the University of California as the associated organization.
Collaborations
The patent lists Charles E. Prussak and George F. Widhopf among Oh’s fellow inventors, indicating collaboration on the CAR-T invention.
Conclusion
Christopher S. Oh’s patent activity highlights his contribution to collaborative research on CAR-T cell approaches for treating hematological and solid tumor cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile